Ingenuity Systems and CHDI Announce Multi-Year Deal for Disease-Specific Knowledge Platform
News Jul 15, 2008
Ingenuity Systems and CHDI Foundation, Inc. have announced a multi-year agreement for CHDI to use IPA as a platform to integrate Ingenuity-curated information relevant to Huntington’s disease. CHDI researchers will be able to leverage this knowledge using the complete set of analysis tools and structured knowledge already available in IPA.
Ingenuity is advancing the development of disease-specific solutions by allowing organizations such as CHDI to use IPA as a platform to access both internal documents and disease-specific knowledge. This new type of solution is designed to address longstanding information management challenges by providing a uniform platform to capture and access diverse information resources, allowing for efficient knowledge management and improved business value.
This solution is made possible by the Ingenuity Ontology, which organizes and structures the knowledge in IPA and which can be applied broadly across internal information and customized with disease-specific knowledge for corporate use as well as that of academic and government institutions.
Domainex Appoints Dr Bodo Spori as Head of Business Development for EuropeNews
Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce the appointment of Dr Bodo Spori as Head of Business Development for Europe.READ MORE
Empowering Women in Technology Key to Boosting UK EconomyNews
A new report launched at London Stock Exchange for International Women’s Day, reveals the critical role women play in driving economic growth across the UK, with detailed research on 1,279 women-led companies showing a total contribution of £25.9 billion in revenue to the UK economy.READ MORE
Synthetic Biology Breakthrough Means Bacteria Could Produce Our Essential DrugsNews
Bacteria could be programmed to efficiently produce drugs, thanks to breakthrough research into synthetic biology using engineering principles.READ MORE